Skip to content

Advertisement

Open Peer Review Reports for: Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
8 Mar 2017 Submitted Original manuscript
10 Apr 2017 Reviewed Reviewer Report - Enrico Derenzini
13 Apr 2017 Reviewed Reviewer Report - Debmalya Bhattacharyya
17 Apr 2017 Reviewed Reviewer Report - Amit Singh
4 May 2017 Author responded Author comments - Jianping Lai
Resubmission - Version 2
4 May 2017 Submitted Manuscript version 2
16 May 2017 Reviewed Reviewer Report - Amit Singh
25 May 2017 Reviewed Reviewer Report - Enrico Derenzini
16 Jun 2017 Author responded Author comments - Jianping Lai
Resubmission - Version 3
16 Jun 2017 Submitted Manuscript version 3
5 Jul 2017 Author responded Author comments - Jianping Lai
Resubmission - Version 4
5 Jul 2017 Submitted Manuscript version 4
13 Jul 2017 Author responded Author comments - Jianping Lai
Resubmission - Version 5
13 Jul 2017 Submitted Manuscript version 5
Publishing
24 Jul 2017 Editorially accepted
28 Jul 2017 Article published 10.1186/s12885-017-3501-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement